Cancer-related accelerated ageing and biobehavioural modifiers: a framework for research and clinical care.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

A growing body of evidence indicates that patients with cancer who receive cytotoxic treatments (such as chemotherapy or radiotherapy) have an increased risk of accelerated physical and cognitive ageing. Furthermore, accelerated biological ageing is a suspected driving force behind many of these observed effects. In this Review, we describe the mechanisms of biological ageing and how they apply to patients with cancer. We highlight the important role of specific behavioural factors, namely stress, sleep and lifestyle-related factors such as physical activity, weight management, diet and substance use, in the accelerated ageing of patients with cancer and cancer survivors. We also present a framework of how modifiable behaviours could operate to either increase the risk of accelerated ageing, provide protection, or promote resilience at both the biological level and in terms of patient-reported outcomes.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Nat Rev Clin Oncol

Title: Nature reviews. Clinical oncology

Publisher: Springer Science and Business Media LLC

ISSN (Electronic): 1759-4782

ISSN (Print): 1759-4774

Publication date (Electronic): March 2022

Volume: 19

Issue: 3

Affiliations

[1 ] Norman Cousins Center for Psychoneuroimmunology, Jane and Terry Semel Institute for Neuroscience and Human Behaviour, University of California, Los Angeles, CA, USA. JCarroll@mednet.ucla.edu.

[2 ] Department of Psychiatry & Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. JCarroll@mednet.ucla.edu.

[3 ] Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA, USA. JCarroll@mednet.ucla.edu.

[4 ] Norman Cousins Center for Psychoneuroimmunology, Jane and Terry Semel Institute for Neuroscience and Human Behaviour, University of California, Los Angeles, CA, USA.

[5 ] Department of Psychiatry & Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

[6 ] Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA, USA.

[7 ] Department of Psychology, University of California, Los Angeles, CA, USA.

[8 ] Department of Health Policy & Management, Fielding School of Public Health, University of California, Los Angeles, CA, USA.

[9 ] Department of Medicine (Hematology-Oncology), David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

Article

Publisher Item ID: 10.1038/s41571-021-00580-3

DOI: 10.1038/s41571-021-00580-3

PubMed ID: 34873313

SO-VID: b1cd53dc-1c0c-4422-8bb0-94ae393fa326

History

Data availability:

Comments

Comment on this article

scite_

Cited by 18

See all cited by

- Version 1